Clinical study of serum soluble Tim-3 predicting response and prognosis of patients with hepatocellular carcinoma treatedby transcatheter arterial chemoembolization

XIONG Bin; HE Xiuzhen; YE Xiaolan; WANG Dongying; ZHANG Jinli

doi:10.3969/j.issn.1009-0460.2022.06.008

Home>Articles>Clinical study of serum soluble Tim-3 predicting response and prognosis of patients with hepatocellular carcinoma treatedby transcatheter arterial chemoembolization

DOI: 10.3969/j.issn.1009-0460.2022.06.008

Clinical study of serum soluble Tim-3 predicting response and prognosis of patients with hepatocellular carcinoma treatedby transcatheter arterial chemoembolization

XIONG Bin

HE Xiuzhen

YE Xiaolan

WANG Dongying

ZHANG Jinli

Machine-generated Keywords：

Publication Date：2022-06-28

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：6( 527-532 )

Chinese Clinical Oncology

ISTICPKU

ISSN：1009-0460

Year, Vol.(Issue)：2022,27(6)